News and publishing service for medical and biotechnology related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for medical and biotechnology related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
Headlines
Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care
Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy
New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection
The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
BioMedNewsBreaks
BioMedNewsBreaks – BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB), SpayVac-for-Wildlife Inc. Expand License Agreement
April 22, 2025
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Host Investor Webinar Highlighting Cancer Immunotherapy Pipeline
Calidi Biotherapeutics Inc. (CLDI)
April 22, 2025
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist in Established Category
Nutriband Inc. (NTRB)
April 17, 2025
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Clearance to Begin Trials for CLD-201 in Solid Tumors
Calidi Biotherapeutics Inc. (CLDI)
April 17, 2025
BioMedNewsBreaks – ProPhase Labs Inc. (NASDAQ: PRPH) Closes $23.6M Sale to Focus on Core Businesses
ProPhase Labs Inc. (PRPH)
April 16, 2025
View More BioMedNewsBreaks
BioMedWire Articles
UnitedHealth Records Lower Revenue as Medical Advantage Use Grows
Astiva Health
April 22, 2025
Nutriband Inc. (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery
Nutriband Inc. (NTRB)
April 22, 2025
Soligenix Inc. (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat
Soligenix Inc. (SNGX)
April 21, 2025
Study Finds Link Between Childhood Maltreatment and Elevated Risk of Psoriasis, Rheumatoid Arthritis
Soligenix Inc. (SNGX)
April 21, 2025
The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
CNS Pharmaceuticals Inc. (CNSP)
April 17, 2025
View All BioMedWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
Official NewsWire Relationships
BioMedWire Currently Accepts
Bitcoin
Bitcoin Cash
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000